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Pleural effusion is a common problem dealt by most of the practicing clinicians. Some causes for pleural
effusion are less often considered as a differential diagnosis owing to its rarity. Here we report a case of
renal amyloidosis on alternate day haemodialysis for about two months time presenting with left sided
pleural effusion. On evaluation this turned out to be a case of amyloidosis on thoracoscopic pleural bi-
opsy suggesting the possibility of Primary systemic amyloidosis.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Case report
A forty two year old ladywas referred to us from the department
of nephrology with dyspnoea and left sided pleuritic chest pain of
one week duration. She was managed in the nephrology ward as a
case of synpneumonic effusion with antibiotics and other sup-
portive measures. She was an established case of renal amyloidosis
and was being worked up as a prospective transplant case. She was
detected to have hypertension in the past and also gave history of
preeclampsia and frequent foetal loss. She was thoroughly worked
up for the evidence of collagen vascular disease which were
negative. She had proteinuria, hypothyroidism and hypertension.
Her renal biopsy revealed mild mesangial cellularity, Congo red
positive eosinophil material in the glomeruli, tubular atrophy,
interstitial inﬂammation and thickened vessel wall and this was
reported as consistent with renal amyloidosis.
There was evidence of massive left side pleural effusion with
mediastinal shift on digital Chest X-ray Fig. 1. Thoracocentesis was
done and it initially drained straw coloured ﬂuid which later on
turned to hemorrhagic ﬂuid on subsequent aspirations. She did not
have oliguria, haematuria. There was history of loss of appetite,
exertional dyspnoea and orthopnoea for last two weeks. Two of her
maternal uncles had chronic kidney disease, details of which were
not known. Her renal functions gradually worsened over a period of
eight years and she was diagnosed as stage V Chronic Kidney dis-
ease. She was initiated on haemodialysis since last two weeks and
an alternate day schedule was planned. Pleural ﬂuids study showed
low ADA, exudative effusion with a total count of 300 cells/mm3
with 79% lymphocytes.þ91 9847283847; fax: þ91
Ltd. This is an open access article uThe pleural ﬂuid cytology did not reveal any malignant cells. She
was subjected to repeated thoracocentesis, alternate day haemo-
dialysis and blood transfusions on top of broad spectrum antibi-
otics. Her Mantoux was non reactive. She was also onweekly doses
of erythropoietin, antihypertensives, oral soda bicarbonate, di-
uretics and iron supplements. She was on thyroxine replacement
following thyroidectomy for last ﬁfteen years. Blood investigations
during admission showed Hb-8.4 gm%, TC-6000 cells/mm3, DC-
P76L24, ESR-90 mm/h. Her renal function values were
S.Creatinine-13.1, Urea-155 mg%. Serum Potassium was 4.1 meq/L.
Her total protein was 5.9 gm% with albumin 3 gm%. Her serum
electrophoresis did not reveal any abnormal paraprotein. Her
skeletal survey also was normal.
She had worsening dyspnoea while she was in the nephrology
ward and was shifted to our side and was subjected to a thoraco-
scopy. Under conscious sedation and local anaesthesia, single port
Thoracoscopy was performed by the Jacobe's technique. Pleural
space was entered after draining around one litre of hemorrhagic
ﬂuid under controlled suction. Lung collapsed partially and few
adhesions could be seen. Parietal Pleura revealed sheets of yellow
granular nodules Fig. 2. Biopsywas taken and haemostasis attained.
Histopathology of the nodule showed evidence of Congo red pos-
itive abundant amyloid material Fig. 3. Intercostal tube drainage
was put. Her CT chest taken prior to Thoracoscopy showed massive
pleural effusion on the left with minimal effusion in the right side
shown by white bold arrows in Fig. 4.
Her post thoracoscopic chest X-ray PA showed evidence of
cardiomegaly and bilateral costophrenic blunting supporting the
pre procedural CT evidence of bilateral effusion Fig. 5.
In view of her gross cardiomegaly a cardiology consultation was
taken and the echocardiogram done subsequently did not reveal
any evidence of pericardial effusion or cardiac amyloidosis. Hence
she was managed conservatively with intercostal tube drainage,
diuretics, hydrolazine, cilnidipine, weekly erythropoietin, parennder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. Chest X-ray showing left massive effusion.
Fig. 3. Congo red staining positive material.
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sodabicarbonate. She continued to have drainage which made
pleurodesis not possible and during the course of her stay in the
pulmonary medicine unit she started developing more effusion on
the right side Fig. 6.
Hence she was presumed to have primary systemic amyloidosis
with possibly bilateral pleural deposits on the basis of thoraco-
scopic biopsy on the left side and renal amyloid diagnosed on renal
biopsy. Shewas transferred back to the parent nephrology unit for a
combination therapy of Bortezomib, Lenalidomide and dexameth-
asone along with hemodialysis. Other agents tried with varyingFig. 2. Thoracoscopic view of amyloid deposits.success in stem cell transplant ineligible primary systemic
amyloidosis patients includes antimetabolites like cyclophospha-
mide, vincristine, adriamycin or proteasome inhibitors and
immunomodulatory agents which includes bortezomib, melpha-
lan,colchicine, thalidomide and pomalidomide.
Discussion
Amyloidosis is a rare disorder with a potential for multisystem
involvement, characterized by extracellular deposition of different
proteins as insoluble beta pleated sheets resulting in disruption of
the function of the organ affected. Amyloidosis had been classiﬁed
over the years based on the site of deposition and presence or
absence of other diseases [1]. The term “Generalized” or “Systemic”
had been used to describe deposition in multiple anatomic sites
and “localized” used to describe deposition in one anatomic site.
The term “secondary” used to describe patients with coexistentFig. 4. CT chest showing (L) sided massive effusion and right sided minimal effusion
(Bold arrow).
Fig. 5. Post thoracoscopy chest X-ray PA.
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such coexistent disease [2]. In our patient there was evidence of
involvement of two organ systems and there was no evidence of
any other co existent diseases.
The most common cause of the respiratory amyloid disease is
secondary to systemic AL Amyloidosis which accounts for up to 80%
of pulmonary amyloid [3]. Moreover, it has been reported that 88%
of patients with systemic amyloid have pulmonary disease [4].
Nomenclature Committee of the International Society of
Amyloidosis 2010 recommends identiﬁcation of an amyloid ﬁbril
protein in tissue deposits which exhibit afﬁnity for Congo red and
green birefringence when viewed by polarization microscopy [5,6].
Furthermore, the protein must have been unambiguously charac-
terized by protein sequence analysis (DNA sequencing in the case of
familial diseases). To date, there are twenty seven known extra-
cellular ﬁbril proteins identiﬁed in humans. Amyloid derived from
immunoglobulin light-chain protein (AL disease) is most frequently
involved in manifestations in the lung in both systemic and local-
ized forms of the disease. Protein sequencing analysis was not
attempted in our case.Fig. 6. Right effusion with ICD on left side.Pulmonary presentations
1. Tracheobronchial amyloidosis: nodular or diffuse submucosal
involvement
2. Diffuse alveolar-septal: presents as interstitial lung disease
3. Single or multiple parenchymal nodules: peripheral, subpleural
and could be bilateral
4. Mediastinal adenopathy with egg shell or popcorn calciﬁcation
5. Pleural effusion: unilateral or bilateral. Could be transudative or
exudative.
Amyloid deposition is widespread in AL disease, although only
speciﬁc organs may be clinically involved. Patients may present
primarily with respiratory symptoms that warrant pulmonary
workup leading to the diagnosis of amyloidosis [1,7]. Symptoms of
pulmonary amyloidosis are very non speciﬁc and hence require a
high degree of clinical suspicion. Amyloid nodules in the lung pa-
renchyma are most often asymptomatic and are usually incidental
ﬁndings on imaging studies. These nodules tend to calcify, and
sometimes they may cavitate. Diffuse alveolar-septal amyloidosis
related to systemic AL disease may present with interstitial lung
disease pattern or evenmore frightening symptoms of haemoptysis
due to dissection of pulmonary arteries inﬁltrated by amyloid pro-
tein deposits ormassive pulmonaryembolism related to thrombosis
of inferior vena cava [8]. Mediastinal or hilar adenopathy is less
common than extrathoracic adenopathy in patients with systemic
AL disease. They can cause luminal narrowing of the airways and
thus may lead to post obstructive atelectasis and/or pneumonia.
However, thesepatientsmaysometimespresentwith cervical nodes
that may enlarge, become tender and can mimic sarcoidosis. Johns
Hopkins Hospital examined the association of cardiac and pulmo-
nary amyloid inﬁltration in autopsy data from 26 patients with
systemicALdisease. Pulmonaryamyloiddepositionwasnot found in
the absence of cardiac disease [4,9]. Hence if pulmonary amyloid is
suspected it is imperative that one should be looking for its presence
within themyocardium.However this dictumcouldnotbeproved in
our case with echocardiographic evaluation which is supposed to
have speciﬁc appearance in case of myocardial inﬁltrative disease.
Beta-2 microglobulin ﬁbril precursor protein related systemic
amyloidosis is reported in chronic renal impairmentpatients on long
term dialysis and with periarticular involvement. Our patient was
started on renal dialysis only twomonths back and she did not have
any features to suggest joint involvement.
Pleural effusion
Pleural effusions in patients with amyloidosis which is a rare
cause for massive effusion can cause dyspnoea and may require
repeated thoracentesis to relieve symptoms as was the situation in
our case which ﬁnally required intercostal tube drainage for
dyspnoea management. One of the ﬁrst reports of amyloid-
associated pleural effusion included ﬁve patients by Kavuru et al.
[10]. These authors found that pleural effusions in the majority of
their patients (60% in their series) were believed to be related to
either congestive heart disease or nephrotic syndrome, and only
40% of pleural effusions were “idiopathic”. Despite this they found
that even those patients with transudative effusions had pleural
inﬁltration with amyloid on biopsy, as what has happened in our
case also. Direct amyloid inﬁltration of the parietal pleura was
responsible for large recurrent pleural effusions.
Large, recurrent effusions can also occur in the setting of co
existent signiﬁcant cardiac dysfunction and pleural amyloid. Their
claim was supported by thoracoscopic descriptions of pleural
studding and histological evidence of amyloid inﬁltrating pleural
surfaces on biopsy [10]. Although uncommon, pleural effusions in
S. George et al. / Respiratory Medicine Case Reports 13 (2014) 39e4242patients with Primary pulmonary amyloidosis can be hemorrhagic
[11]. In our case the effusion was uniformly hemorrhagic.
Chylous effusions occur in patients with extensive amyloid
burden due to direct inﬁltration of mediastinal nodes by amyloid
rather than bymechanical obstruction [12]. Patients with nephrotic
syndrome and serum albumin levels <2.5 gm/dL do not frequently
manifest pleural effusion in the absence of congestive heart failure.
Thoracoscopic view reveals amyloid deposits studding the parietal
pleural surface, supporting the diagnostic utility of even closed
needle pleural biopsies in centres not having thoracoscopic facil-
ities. Hence transudative massive pleural effusion in established
cases of renal amyloidosis merits evaluation with pleural biopsy.
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